Crossmark

HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma

Published Online: 2021-11-08

Authors

Tian, Tian

Hong, Fu

Wang, Zhiwen

Hu, Jiaru

Chen, Ni

Lv, Lei https://orcid.org/0000-0002-1889-7018
Yi, Qiyi https://orcid.org/0000-0001-5143-8828
License Information

Text and Data Mining valid from 2021-11-08

Version of Record valid from 2021-11-08
More Information

Article History

Received: 10 August 2021

Revised: 23 October 2021

Accepted: 26 October 2021

First Online: 8 November 2021

Ethics statement

: The operation of mice in our study was evaluated and approved by the Committee on the Ethics of Animal Experiments of University of Science and Technology of China.

: The authors declare no competing interests.

Document is current